Adherence to insulin regimens remains a significant barrier, with real‐world studies indicating that fewer than 30% of patients with T2D achieve the recommended HbA1c target of < 7% within a year of initiating basal insulin [9]. Here, INS is linked to type 2 diabetes mellitus.